You'll hear more controversy about ezetimibe (Vytorin, Zetia)

You'll hear more controversy about ezetimibe (Vytorin, Zetia).

The latest data suggest that ezetimibe (Zetia) doesn't reduce atherosclerosis as well as niacin...when added to a statin.

This has experts scratching their heads. Ezetimibe lowers LDL better than niacin...and the current thinking is "lower is better."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote